%0 Journal Article
%T A novel PIK3CA hot-spot mutation in breast cancer patients detected by HRM-COLD-PCR analysis.
%A Debouki-Joudi S
%A Ben Kridis W
%A Trifa F
%A Ayadi W
%A Khabir A
%A Sellami-Boudawara T
%A Daoud J
%A Khanfir A
%A Mokdad-Gargouri R
%J Breast Dis
%V 43
%N 1
%D 2024
%M 38943378
暂无%R 10.3233/BD-240005
%X <B>UNASSIGNED: </B>The PI3K protein is involved in the PI3K/AKT/mTOR pathway. Deregulation of this pathway through PIK3CA mutation is common in various tumors. The aim of this work is to identify hotspot mutation at exons 9 and 20 in Tunisian patients with sporadic or hereditary breast cancer.<BR><B>UNASSIGNED: </B>Hotspot mutations in exon 9 and exon 20 of the PIK3CA gene were identified by QPCR-High Resolution Melting followed by COLD-PCR and sequencing in 63 (42 sporadic cases and 21 hereditary cases) tumor tissues collected from Tunisian patient with breast cancer. MCF7, and BT20 breast cancer cell lines harboring the PIK3CA hotspot mutations E545K and H1047R in exon 9 and exon 20 respectively, were used as controls in HRM experiments.<BR><B>UNASSIGNED: </B>PIK3CA hotspot mutations were detected in 66.7% (28 out of 42) of sporadic BC cases, and in 14.3% (3 out of 21) of hereditary BC. The E545K and the H1048Y were the most prevalent mutations identified in patients with sporadic and hereditary BC, whereas the H1047R hotspot mutation was not found in our patients. Statistical analysis showed that PIK3CA mutation associated with an aggressive behavior in patients with sporadic BC, while it's correlated with age, tumor stage and tumor size in the group patients with hereditary breast cancer.<BR><B>UNASSIGNED: </B>Our results showed a novel PIK3CA hotspot mutation in Tunisian breast cancer patients detected by HRM-COLD-PCR. Moreover, the absence of PIK3CA hotspot mutation associated with good prognosis.